focus -WSS

focus

author：explore 2025-09-28 02:28:38 - browse：7

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Doctors' information doesn't help them choose wisely when sick

Wikipedia

WSS

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Robert F. Kennedy is pitching centrism on health, even on abortion

Senators start work on Medicare physician payment reform

New chief aims to remake Sanofi Genzyme

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

How digital tools helped lower hypertension in marginalized patients

focus

focus

focus

How to save PrEP access — and even expand it

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Peter Hotez and the public health issue of online harassment

New chart reveals military’s vast involvement in Operation Warp Speed

Psychedelics group wrestles with new pharma identity

New chart reveals military’s vast involvement in Operation Warp Speed

Supreme Court strikes down use of affirmative action

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Alkermes shareholders re

Reframing the conversation around gain

focus

How digital tools helped lower hypertension in marginalized patients

New chart reveals military’s vast involvement in Operation Warp Speed

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

knowledge

entertainment

Wikipedia

focus